BPC-157 demonstrates exceptional safety in animal toxicology studies, with comprehensive evaluations in mice, rats, rabbits, and dogs failing to establish a lethal dose (LD) across wide dose ranges extending from standard research doses (6 g/kg) to levels exceeding 1000-fold higher concentrations (20 mg/kg), with no evidence of acute toxicity, organ-specific damage, or systemic adverse effects even following repeated high-dose administration
Mejora de enfermedades crnicas: Los estudios sugieren que el BPC 157 puede tener el potencial de reducir las reacciones inflamatorias y los sntomas asociados con enfermedades crnicas
The company is developing targeted, prescription antioxidant therapies that aim to stop chemically aggressive oxygen molecules from damaging tissue
Supplements like Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) are precursors that the body can use to synthesize NAD+, offering potential avenues for repletion
and this is my testimony and the different treatments for it